Numerous analyses have shown that enhanced expression of NRP-1 and NRP-2 in colorectal cancer tissues correlates with adverse patient prognosis, including a higher risk of metastasis and shorter overall survival [20,22]. This evidence concerns the gene NRP2 and colorectal cancer.